AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 111 min read$ATEC

Miles Patrick purchased $1.0M of ATEC

Miles Patrick (CEO) purchased 115,000 shares of Alphatec Holdings, Inc. (ATEC) at $8.81 ($1.01M total) on 2026-09-10.

Original reporting
SEC EDGAR · Miles Patrick
Published Sep 11, 2026, 12:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ATEC
Bullish
high confidence
Mentioned
$ATEC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATECBullishMed
01

Why it matters

The CEO's purchase may be interpreted as a vote of confidence, influencing investor sentiment.

02

Market read

The insider purchase is a fresh, material event that could affect short-term trading decisions.

03

What to watch

Potential upcoming earnings or regulatory news not disclosed could affect the stock.

Relevance 7/10Novelty 8/10Timing: after-market 2026-09-10 filing

Background

Form 4 filing reveals insider transactions; such disclosures are primary sources of corporate activity.

Company-level read

Ticker impact

$ATECBullishHigh confidence
Context

CEO Miles Patrick bought 115,000 shares for $1.01M, increasing his stake to over 5.8 million shares.

Expected impact

Possible modest price uptick in the next trading session.

Evidence & confidence

CEO insider buying $1M is material for a mid-cap; markets often react positively to executive purchases.

Market effects

Sector

May signal confidence in the medical device sector, but limited broader impact.

Regional

Primarily U.S. market; minimal regional effect.

Global

Low global relevance.

Counterpoint

What could challenge this read

Insider buying could be a preemptive move before a pending negative catalyst.

Key entities

  • Company
    Alphatec Holdings, Inc.

    Medical device manufacturer.

  • Executive
    Miles Patrick

    CEO and Director of Alphatec.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ATEC insider trading history →

Related articles

OCT 30
$ATECMedAI 8/10

Alphatec Q3 Earnings Call Highlights

Alphatec reported Q3 earnings with higher margins (72%) and positive free cash flow ($6M). Full-year 2026 revenue guidance was reduced to $862M due to market softness and supply constraints. The company highlighted growth in EOS and Valence platforms. Alphatec ended the quarter with $135M in liquidity.

finance.yahoo.com6 min
OCT 29
$ATECMedAI 8/10

ATEC Reports Third Quarter Financial Results – Ortho Spine News

Alphatec Holdings (ATEC) reported Q3 2026 revenue of $221M, up 13% YoY, with surgical revenue at $202M, up 14%. Adjusted EBITDA was $38M, or 17% of revenue, up 400 bps YoY. Case volumes grew 20% and new surgeon users increased 25%. The company expects full-year 2026 revenue of $862M, adjusted EBITDA of $137M, and $10M in free cash flow.

orthospinenews.com6 min
OCT 29
$ATECMedAI 8/10

Alphatec: Q3 Earnings Snapshot

Alphatec Holdings Inc. (ATEC) reported a Q3 loss of $5.5 million, or 3 cents per share, with adjusted earnings of 9 cents per share. Revenue was $221.2 million, missing estimates of $224.3 million. The company expects full-year revenue of $862 million. ATEC shares have fallen 46% YTD and 31% over the past year.

finance.yahoo.com2 min